Research location
Numakunai
Japan
Advertisement
Research activity in Numakunai
JapanCureCurrent currently publishes aggregate city-level research activity for this location: 43 trials and 59 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Numakunai
43 linked trials · page 1 of 1General Use-results Surveillance With Awiqli in Patients With Diabetes MellitusNCT06807190 · 2025-04-15 · 1 site observation
RECRUITING
Special Use - Results Surveillance on Long-term Use With Wegovy®NCT06283667 · 2024-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)NCT05729711 · 2023-04-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightNCT05813925 · 2023-04-03 · 1 site observation
COMPLETED
LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)NCT05677308 · 2023-03-07 · 1 site observation
COMPLETED
Forxiga HF General Drug Use-Results StudyNCT04865406 · 2021-05-10 · 1 site observation
COMPLETED
GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.NCT04838743 · 2021-04-23 · 1 site observation
COMPLETED
IMFINZI Study in Patients With Extensive Stage Small Cell Lung CancerNCT04854590 · 2021-04-22 · 1 site observation
COMPLETED
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeNCT04718389 · 2021-01-26 · 1 site observation
COMPLETED
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®NCT04469855 · 2020-07-27 · 4 site observations
COMPLETED
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisNCT03971253 · 2019-09-02 · 1 site observation
COMPLETED
FASENRA SCEI for Long-term UseNCT03588546 · 2018-05-31 · 1 site observation
COMPLETED
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)NCT03114657 · 2017-03-29 · 1 site observation
TERMINATED
Forxiga Tablets Specific Clinical Experience Investigation for Long-term UseNCT02200666 · 2014-10-03 · 1 site observation
COMPLETED
Forxiga Tablets Specific Clinical Experience Investigation for ElderlyNCT02200627 · 2014-09-01 · 1 site observation
COMPLETED
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation
COMPLETED
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)NCT02115750 · 2014-05-01 · 1 site observation
COMPLETED
Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02105974 · 2014-04-07 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerNCT01966471 · 2014-01-31 · 1 site observation
COMPLETED
Specific Clinical Experience Investigation for Long-term Use of Bydureon.NCT01940770 · 2013-10-18 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.NCT01929317 · 2013-08-28 · 2 site observations
TERMINATED
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationNCT01867125 · 2013-07-25 · 1 site observation
COMPLETED
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)NCT01740427 · 2013-02-22 · 1 site observation
COMPLETED
A Study in Participants With Moderate to Severe Rheumatoid ArthritisNCT01711359 · 2012-11-01 · 1 site observation
COMPLETED
Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01713075 · 2012-11-01 · 1 site observation
COMPLETED
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast CancerNCT01684215 · 2012-10-19 · 1 site observation
COMPLETED
A Study in Moderate to Severe Rheumatoid ArthritisNCT01710358 · 2012-10-01 · 1 site observation
COMPLETED
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast CancerNCT01663727 · 2012-08-27 · 1 site observation
COMPLETED
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerNCT01358877 · 2011-11-08 · 1 site observation
COMPLETED
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)NCT01817569 · 2011-02-13 · 1 site observation
COMPLETED
Pulmicort Turbuhaler 100/200 Specific Clinical Experience InvestigationNCT01203904 · 2010-09-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)NCT01120184 · 2010-07-31 · 1 site observation
COMPLETED
A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisNCT00870467 · 2009-03-01 · 1 site observation
COMPLETED
Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With PlaceboNCT00762411 · 2008-09-01 · 1 site observation
COMPLETED
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsNCT00667810 · 2008-06-01 · 1 site observation
TERMINATED
Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid ArthritisNCT01076959 · 2008-06-01 · 13 site observations
COMPLETED
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerNCT00567190 · 2008-02-12 · 1 site observation
COMPLETED
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsNCT00676143 · 2008-01-01 · 1 site observation
TERMINATED
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)NCT00537082 · 2007-09-01 · 1 site observation
COMPLETED
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 StudyNCT00485069 · 2007-06-01 · 1 site observation
COMPLETED
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)NCT00434304 · 2007-04-09 · 1 site observation
COMPLETED
Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast CancerNCT00334802 · 2006-06-01 · 1 site observation
COMPLETED
Double-Blind Study of Miglitol in Japanese With type2 DiabetesNCT00380822 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.